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Abstract
We describe a novel, simple and low-cost protein microarray strategy wherein the microarrays are generated by printing
expression ready plasmid DNAs onto slides that can be converted into protein arrays on-demand. The printed expression
plasmids serve dual purposes as they not only direct the synthesis of the protein of interest; they also serve to capture the
newly synthesized proteins through a high affinity DNA-protein interaction. To accomplish this we have exploited the high-
affinity binding (,3–7610
213 M) of E. coli Tus protein to Ter, a 20 bp DNA sequence involved in the regulation of E. coli
DNA replication. In our system, each protein of interest is synthesized as a Tus fusion protein and each expression construct
directing the protein synthesis contains embedded Ter DNA sequence. The embedded Ter sequence functions as a capture
reagent for the newly synthesized Tus fusion protein. This ‘‘all DNA’’ microarray can be converted to a protein microarray
on-demand without need for any additional capture reagent..
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Introduction
The rapid development of genomic databases, bioinformatics
tools, laboratory robotics and enabling technologies such as cDNA
and oligonucleotide microarrays have provided new insights and
understanding into biological and disease processes thru the global
analysis of gene expression patterns. Continued development of
high-throughput platforms, such as protein microarray technolo-
gies, are essential to furthering our understanding of protein
function, quantitative proteomics, molecular interactions and
protein profiling [1–3]. Unfortunately, inherent cost and technical
limitations, including the required production of large libraries of
purified proteins and long-term maintenance of array stability and
integrity, have caused protein microarray development to lag
behind that of DNA microarrays [2,4]. Nevertheless, despite these
limitations, several groups have demonstrated proof-of-concept
and the potential of protein microarray technology [4–9].
In an effort to address these issues, Nord et al. developed an
alternative platform, termed protein microbead display, wherein
proteins are captured via antigen-antibody binding as they are
synthesized [10]. This technology utilizes a biotin labeled PCR
product (containing a T7 promoter and a FLAG epitope in-frame
with two IgG binding domains) anchored onto microbeads
through streptavidin-biotin affinity binding. Anti-FLAG antibody
is then immobilized onto the same microbead. The beads are
incubated in a coupled cell-free transcription-translation extract to
produce the targeted protein. Newly synthesized proteins are
trapped via Flag peptide (antigen)-Flag antibody interaction. More
recently, Ramachandran et al. [11] applied a similar antibody
mediated protein anchoring technology to a microarray format.
This platform employs purified expression construct DNAs
arrayed onto a microscope slide via biotin-avidin interaction.
The encoded inserts are fused with GST protein to produce GST-
fusion proteins. The slides are simultaneously printed with
polyclonal GST antibody to capture the newly synthesized GST
fusion-proteins following coupled cell-free transcription-translation
on the surface of the microarray. In both cases, newly synthesized
proteins are captured through protein-protein (antigen-antibody)
interactions. Although both technologies have been successfully
employed, they also have their limitations. First, both platforms
require a second protein, the antibody, to capture the synthesized
fusion-protein. This antibody needs to be purified which adds to
both labor and cost. Second, given that proteins (i.e. the capture
antibody) need to be arrayed with the expression construct,
maintaining the stability and integrity of the microarrays for
extended periods of time remains an issue. We have addressed
both of these issues by eliminating the need for antibody or other
capture reagent to immobilize the newly synthesized proteins onto
the microarray surface. In our system, the expression vector DNA
not only directs the synthesis of each protein, but also serves to
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surface. Since only plasmid DNA is printed, array fabrication is
simple and array stability is not an issue. To accomplish this we
have exploited the high-affinity binding (,3–7610
213 M) of E.
coli Tus protein to Ter, a 20 bp DNA sequence involved in the
regulation of E. coli DNA replication [12,13]. In our system, each
protein of interest is synthesized as a Tus fusion protein and each
expression construct directing the protein synthesis contains
embedded Ter DNA sequence. The embedded Ter sequence
functions as a capture reagent for the newly synthesized Tus fusion
protein.
Methods
A. Construction of base microarray plasmid
For convenience, a recombinational cloning system was used
(Invitrogen, Carlsbad, CA). First, a destination vector was made
using Tus as the carboxy fusion partner. A modified, Tus (E47Q)
with higher affinity for the Ter DNA sequence [12] was amplified
from plasmid DNA by standard procedure. Oligos used for Tus
amplifications were:
Forward- 59-ATT TTA GCT AGC GGA GGT GCG CGT
TAC GAT CTC GTA GAC CGA CTC-39 and Reverse 59-
TATATT CAA TTG TTA atg atg gtg atg atg gtg ATC TGC
AAC ATA CAG GTG CAG CCG TGG 39.
Restriction sites NheI and MunI are indicated as bold and
underlined. A six-histidine tag (small letters) was incorporated in
reverse oligo so that Tus will be his-tagged for downstream
identification.
The PCR product was purified, digested with NheI and MunI,
run on an agarose gel, and the fragment excised. The fragment
was then cloned into a derivative pDest47 (Invitrogen, Carlsbad,
CA) termed pDest472 that had been digested with the same
enzymes to create pDest 472-Tus. Correct clones were selected by
digestion and verified by sequencing.




Following annealing, these oligos form a double stranded Ter
site with ClaI and NgoMIV overhangs. The annealed oligo was
cloned in pDest 472-Tus digested with NgoMIV and ClaI to
create pDest Microarray TT-1. The clone was verified by
sequencing. This is the base plasmid to clone any protein of
interest by recombinational cloning.
In addition to a wild type Ter site, a mutant Ter site was also
tested for Tus fusion capture. The mutant Ter site was obtained
during the course of cloning the wild-type Ter site. The sequence
of the mutant was found to be:
CACTTTAGTTACAACATATTTATT
The site of the mutation is underlined. It has been shown that
mutation at this particular site will reduce binding affinity by
almost 4-fold [11]. This position is equivalent to position 6
according to the nomenclature in the manuscript. The Ter
sequence has been presented in reverse orientation [11].
B. Construction of GFP fusion plasmid
As a proof-of-concept, we cloned GFP as a fusion with Tus.
pEL100 contains eGFP gene in pDonr223 (Invitrogen, Carlsbad,
CA). It contains a Kozak sequence upstream of ATG and no stop
codon at the C-terminus. Thus, upon recombinational cloning
into pDest Microarray TT-1, GFP will be fused in frame with Tus.
Recombinational cloning was performed as per manufacturer’s
(Invitrogen, Carlsbad, CA) directions. Finally, the clone was
sequenced to confirm correct insertion.
C. Microarray Fabrication
Microarray protein expression vectors were prepared in 36
standard saline citrate (SSC) in a 384-well plate (Genetix, Boston,
MA) and arrayed on nitrocellulose coated ‘‘Fast Slides’’ (Schlei-
cher & Schuell BioScience, Keene, NH) using a Microgrid II
microarray robot at 50% humidity. Microarray features were
printed at a spacing of 0.55mm (center to center) with 1.2mm
spacing between each sub array. After printing, microarrays were
baked at 80uC for 30 min. Slides were blocked with 0.1% PVP/
0.05% Tween 20 for 1 h prior to expression.
To confirm uniform DNA spotting, a sample slide from each
print set was stained for DNA content using the IDT (Coralville,
IA) Cy3-SpotQC detector oligo (9mers) diluted in 0.1% PVP/
0.05% Tween 20 buffer. Following incubation, slides were washed
16for 3 minutes in 106SSC, 0.2% Sarkosyl, followed by a second
wash in 106SSC for one minute. After a third wash in 26SSC,
slides were dried and scanned with an Axon GenePix 4000
scanner (Figure S1).
D. In situ Expression of Proteins
In situ expression was performed using a cell-free expression
system (TNT Quick coupled transcription/translation system
(Promega, Madison, WI)). In brief, 30 ml of rabbit reticulocyte
lysate, supplemented with methionine, was added directly to the
slide and incubated in a water bath. Expression and immobiliza-
tion were carried out at 30uC for 1.5 hours followed by a 2 hour
incubation at 15uC.
E. Confirmation of Expression and Immobilization of
Expressed Proteins
Expression of GFP-Tus protein was confirmed with a Cy3–Cy5
labeled antibody to the poly-histidine (poly-his) tag. Prior to
incubation with labeled antibody, slides were blocked for 1 hr with
0.1% PVP/0.05% Tween 20. Monoclonal antibodies to poly-his,
GFP (Sigma-Aldrich, St Louis, MO), and beta-globin (Novus,
Littleton, CO) were labeled with fluorescent dye N-hydroxysucci-
nimide (NHS) ester-linked Cyanine 3 (Cy3) and Cyanine 5 (Cy5)
(Amersham, Piscataway, NJ). In brief, 90 ml of antibody diluted to
the concentration of 0.55 mg/ml in 0.1 M sodium bicarbonate/
carbonate buffer pH 9.0 was mixed with 20 mlo f6 0mM of Cy3 or
Cy5 in sodium bicarbonate/carbonate buffer and incubated on ice.
After reaction had proceeded for 90 minutes, 8 ml of Blocking
Buffer (BD Biosciences, San Jose, CA) was added to the solution to
quench the reactions and the solutions were allowed to sit for
another 30 min with additional mixing approximately every
10 min. Unbound dye was removed by passing each sample
through a size-exclusion chromatography spin column (sephadex
G-15 (Sigma Aldrich, St. Louis, MO). Molar concentration for
labeled protein and dye were calculated. The Cy5- labeled anti-his
was mixed with equal amount of the Cy3-labeled anti-his and
diluted in microarray hybridization buffer (0.1% PVP/0.1% Tween
20). Hybridization to the array was performed in an incubation
chamber at 4uC with gentle rocking for at least 12 h. After
incubation, slides were washed 36for 5 minutes each in 106PBS/
0.05%Tween 20, followedbyonewash in106PBSforoneminute.
All washes were performed at 4uC. Slides were dried and scanned
on an Axon GenePix 4000 scanner (Union City, CA), and
fluorescence data were collected and evaluated with the GenePix
Protein Microarray On-Demand
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4000 scanner was set at 100% laser power and 350 PMT gain.
System Design
a) Plasmid DNA encoding protein of interest (POI) was
constructed such that the protein of interest (POI) is fused with
an E. coli protein called Tus. b) The plasmid also contains one or
more Tus binding sites termed Ter. Tus protein binds the Ter
DNA sequence as a monomer with very high affinity, ,3–7610
213 M [11]. c) Plasmids are arrayed by a commercially available
microarray printing robot. d) The POI-Tus fusion protein is
synthesized on the microarray by coupled cell-free protein
synthesis (either mammalian or prokaryotic). If the cocktail is
derived from E. coli, it is made from a Tus minus strain. e) Affinity
of the expressed POI-Tus fusion protein for the Ter sequence is
significantly greater than the antigen-antibody affinity described
by either Nord et al.[9] or Ramachandran et al [10].
Results
The design of the expression construct (pDest-Microarray TT-
1) and basic concept of the array platform are shown in Figure 1
and Figure S1. The basic expression vector is based on the
Gateway (Invitrogen, Carlsbad, CA) recombinational cloning
system making it easier to generate libraries of constructs. To
validate the Tus-Ter DNA-binding protein system for the
development of an in situ self assembling protein array, as well as
demonstrate the specificity of Tus-Ter binding, we printed a
microarray containing a set of clones in pDest-Microarray TT-1
encoding a GFP-Tus-His6 fusion-protein and a Ter site, an
identical vector with a point mutation in the Ter site, and a third
construct without a Ter site.
Anti-his antibody was labeled with Cy3 and Cy5, mixed in
equimolar amounts, and hybridized to this microarray. The results
are shown in Figure 2. We observed significant signal intensities
(arbitrary units of 14000 and 20574 from Cy5 and Cy3
respectively) corresponding to the vector containing a wild-type
Ter site (Fig. 2), confirming the expression and binding of the
GFP-Tus fusion protein. In contrast for the vector without any Ter
site, no significant signal was observed (arbitrary units of 0 and
2463 from Cy5 and Cy3 respectively; Fig. 2). The no-Ter/wild-
type Ter signal ratio (2TER/+TER) is 0 for Cy5 and 0.12 for
Cy3, consistent with significantly higher binding of the fusion
protein to plasmid containing wild-type Ter as compared to
plasmid without any Ter. Similarly, the vector containing a point
mutation in the Ter site showed low to moderate signal (arbitrary
units of 4738 and 10920 from Cy5 and Cy3 respectively; Fig. 2).
The mutated-Ter/wild-type Ter signal ratio (mTER/+TER) is
0.34 for Cy5 and 0.53 for Cy3, indicating that a mutation in the
Ter site results in reduced binding efficiency to the fusion protein.
These data are in complete agreement with previous reports that
Tus binds to the same mutated Ter with 4–6 fold lower efficiency
[12. 13] as well as our own calculations of Tus: Ter and Tus:
mutant Ter binding efficiencies and off rates (Table S1). These
data demonstrate that an intact Ter sequence is necessary and
sufficient for optimal binding to the Tus protein, allowing the
effective binding of Tus-fusion proteins to Ter site(s) present in the
Figure 1. Concept of protein microarray on demand.
doi:10.1371/journal.pone.0003265.g001
Figure 2. Exploiting the specificity of Tus:Ter interaction.
Plasmid vectors encoding a green florescent protein (GFP)- TUS -
poly-histidine fusion protein and a Ter sequence containing a point
mutation (pMUT), a wild-type Ter sequence (pNOMut), and no Ter
sequence were immobilized on the surface of a microarray, incubated
in a cell-free rabbit reticulocyte transcription/translation extract, and
hybridized with Cy-labeled anti-histidine antibody.
doi:10.1371/journal.pone.0003265.g002
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protein microarray fabrication.
In a parallel set of experiments, we have extended these findings
to another DNA-binding protein system (lacI/LacO) and
demonstrate that they can also function to mediate protein
microarray fabrication in a similar manner (DC, CB, KS, JH, and
DM; data not shown).
As a more direct test of this platform, expression plasmids
encoding 14 different proteins were immobilized onto the surface of
a microarray. Expression from eachof the constructs was confirmed
by probing with a labeled antibody directed against the His-tag
engineered into each construct (Fig. 3A). As expected, although an
equal amount of DNA was printed for each feature, the relative
amount of protein produced and retained by each construct varied
modestly, presumably due to characteristic differential transcrip-
tion/translation efficiencies (Fig. 3A and Figure S2). To validate
that the individual targeted proteins were indeed expressed and
captured at their designated location on the microarray, replicate
arrays were probed with antibodies directed against the unique
fusion partners specific for each construct (Fig. 3B and 3C). As
shown, each of the target proteins was expressed and captured at a
specific and designated location that was pre-determined by the
insert encoded in the expression construct printed.
Discussion
We have developed a simple and cost effective strategy for the
rapid generation of protein microarrays. Because only DNA
expression constructs are printed, the inherent cost, stability, and
technical limitations most commonly associated with other protein
microarray strategies are eliminated. As, shown in Figure 1 and
Figure S1, the microarray is fabricated by the printing of DNA
expression constructs that function to not only direct the synthesis
of the desired protein, but also as the ‘capture reagent’ for
immobilization of the encoded protein onto the microarray
surface. The ‘capture reagent’ function of the printed DNA
expression constructs is mediated by the specific and high-affinity
binding (,3–7610
213 M) of E. coli Tus protein to Ter, a 20 bp
DNA sequence. In Table S1 we show that both the specificity and
the high-affinity binding, characteristic of wild-type Tus protein
for Ter, is also true for the cloned versions of Tus:Ter interaction
is maintained in a coupled in vitro transcription/translation system
within a microarray environment. Finally, in Figure 3 we
demonstrate that not only are the designated proteins specifically
expressed, but that the individual expression constructs encoding
each individual protein exclusively captures it’s encoded protein
without detectable diffusion or ‘bleeding’ to adjacent features on
the microarray.
These data support the utility and effectiveness of this platform
as a method for the high-throughput production of low-cost
protein microarrays for the study of protein-protein, protein-
nucleic acid, or protein-small molecule interaction. The open
format of these arrays, together with their long ‘shelf-life’ and
simple low-cost printing scheme, make this a cost-effective,
versatile, production friendly platform amendable to a wide
variety of uses and applications.
Supporting Information
Figure S1 Design of expression construct and basic microarray
fabrication schema
Found at: doi:10.1371/journal.pone.0003265.s001 (0.67 MB TIF)
Figure S2 Validation of microarray printing. Different proteins
fused to TUS - poly-histidine were immobilized on the surface of a
microarray and stained for DNA content as described in Materials
and Methods.
Found at: doi:10.1371/journal.pone.0003265.s002 (9.91 MB TIF)
Table S1
Found at: doi:10.1371/journal.pone.0003265.s003 (0.03 MB
DOC)
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